SynthesisBMC cancer2023

The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis.

Zhenyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.